Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ACTRN12626000153314) titled 'A Phase II study of medicinal cannabis products in the treatment of chronic pain in patients with opioid dependence' on Feb. 6.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Crossover
Type of endpoint: Safety/efficacy
Primary Sponsor: The University of Sydney
Condition:
Low back pain
Opioid dependence
Low back pain
Opioid dependence
Alternative and Complementary Medicine - Other alternative and complementary medicine
Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation
Mental Health ...